
    
      This study is being conducted to help determine whether β-elemene as maintain treatment for
      complete remission patients of newly diagnosed malignant gliomas following standard
      treatment, is able to delay tumor growth, or impact how long people with newly diagnosed
      high-grade glioma. β-elemene will be given 600mg/d,d1-14,q28 days for 6 cycles.
    
  